DE69026295D1 - Pharmazeutische Zusammensetzung gegen durch Vasokonstriktion hervorgerufene Krankheiten - Google Patents

Pharmazeutische Zusammensetzung gegen durch Vasokonstriktion hervorgerufene Krankheiten

Info

Publication number
DE69026295D1
DE69026295D1 DE69026295T DE69026295T DE69026295D1 DE 69026295 D1 DE69026295 D1 DE 69026295D1 DE 69026295 T DE69026295 T DE 69026295T DE 69026295 T DE69026295 T DE 69026295T DE 69026295 D1 DE69026295 D1 DE 69026295D1
Authority
DE
Germany
Prior art keywords
pharmaceutical composition
composition against
diseases
against vasoconstriction
vasoconstriction diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69026295T
Other languages
English (en)
Other versions
DE69026295T2 (de
Inventor
Tetsuro Okabe
Masao Ohkuchi
Akiyoshi Ohhira
Shoichi Kondo
Tomoyuki Koshi
Toshiyuki Edano
Mitsuteru Hirata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kowa Co Ltd
Original Assignee
Kowa Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP31597989A external-priority patent/JPH02291296A/ja
Application filed by Kowa Co Ltd filed Critical Kowa Co Ltd
Publication of DE69026295D1 publication Critical patent/DE69026295D1/de
Application granted granted Critical
Publication of DE69026295T2 publication Critical patent/DE69026295T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE1990626295 1989-01-26 1990-01-24 Pharmazeutische Zusammensetzung gegen durch Vasokonstriktion hervorgerufene Krankheiten Expired - Fee Related DE69026295T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1719789 1989-01-26
JP31597989A JPH02291296A (ja) 1989-01-26 1989-12-05 血管収縮を原因とする疾患の治療剤

Publications (2)

Publication Number Publication Date
DE69026295D1 true DE69026295D1 (de) 1996-05-09
DE69026295T2 DE69026295T2 (de) 1996-10-02

Family

ID=26353679

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1990626295 Expired - Fee Related DE69026295T2 (de) 1989-01-26 1990-01-24 Pharmazeutische Zusammensetzung gegen durch Vasokonstriktion hervorgerufene Krankheiten

Country Status (3)

Country Link
EP (1) EP0384144B1 (de)
CA (1) CA2008122A1 (de)
DE (1) DE69026295T2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0423333A4 (en) * 1988-05-07 1991-07-03 Yamasa Shoyu Kabushiki Kaisha Anti-endoserine antibody
DE4032127A1 (de) * 1990-10-10 1992-04-16 Basf Ag Verwendung von disulfidverbrueckten proteinen und peptiden
RU2201255C1 (ru) * 2001-12-26 2003-03-27 Эпштейн Олег Ильич Лекарственное средство и способ регуляции сосудистого тонуса
TWI613215B (zh) 2012-02-22 2018-02-01 再生元醫藥公司 抗－大－內皮素－１（ｂｉｇ－ｅｔ－１）抗體及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0331100A1 (de) * 1988-03-02 1989-09-06 Takeda Chemical Industries, Ltd. Antiendothelin-Antikörper und ihre Verwendung
EP0423333A4 (en) * 1988-05-07 1991-07-03 Yamasa Shoyu Kabushiki Kaisha Anti-endoserine antibody

Also Published As

Publication number Publication date
EP0384144A1 (de) 1990-08-29
CA2008122A1 (en) 1990-07-26
EP0384144B1 (de) 1996-04-03
DE69026295T2 (de) 1996-10-02

Similar Documents

Publication Publication Date Title
DE10199066I1 (de) Pharmazeutische Zusammensetzung
ATA129892A (de) Pharmazeutische zusammensetzung
DE122004000023I2 (de) Pharmazeutische Zusammensetzung
DE69525148T2 (de) Pharmazeutische formulierung
DE69101931D1 (de) Pharmazeutische Zusammensetzung.
DE4291156T1 (de) Verbesserte pharmazeutische Zusammensetzungen
KR950703566A (ko) 티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof]
FI981777A (fi) Farmaseuttinen ainekoostumus
ATE203400T1 (de) Pharmazeutische formulierungen
FI954767A (fi) Lipofiilisiä lääkeaineita sisältävä farmaseuttinen koostumus
DE3868986D1 (de) Pharmazeutische zusammensetzungen.
DE69006094T2 (de) Pharmazeutische Zusammensetzungen.
MX9200622A (es) Composicion farmaceutica
DE4294862T1 (de) Pharmazeutische Komposition
ITTO920303A0 (it) "composizione farmaceutica antiinfiammatoria"
DE69434210D1 (de) Pharmazeutische antacidzusammensetzung
UA26064A1 (uk) Фармацевтичhа композиція
DE69026295D1 (de) Pharmazeutische Zusammensetzung gegen durch Vasokonstriktion hervorgerufene Krankheiten
DE69012031D1 (de) Optisch aktive Benzylalkoholverbindung und pharmazeutische Zusammensetzung.
DE68915203T2 (de) Pharmazeutische Mischungen.
ATA133288A (de) Pharmazeutische zusammensetzung
ATA321188A (de) Pharmazeutische zubereitung
DE19681529D2 (de) Pharmazeutische Darreichungsform
DE68902056T2 (de) 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung.
DE69324776T2 (de) Pharmazeutische Zusammensetzung die krebserkennende Antikörper enthält

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee